Hims & Hers Branded GLP-1 Shift Lifts Revenue but Squeezes Gross Margins
Hims & Hers says its branded GLP-1 weight-loss push and international expansion grew subscriptions and lifted monthly online revenue per subscriber by 21% year over year. Restructuring for the drug transition cost $4.6 million in the second quarter, and gross margins are expected to stay below historical levels as profitability returns in 2027. Full-year revenue guidance was raised to $3.1 billion–$3.3 billion, aided by an agreed acquisition of Eucalyptus.